A patient with severe acute pancreatitis successfully treated with a new critical care procedure.

It has been accepted widely that excessive humoral mediators play important roles in the pathogenesis of organ failure in patients with severe acute pancreatitis (SAP) and that infection of the pancreas due to bacterial translocation (BT) is the most frequent cause of death in SAP. On the other hand, it has been reported that continuous hemodiafiltration (CHDF) removes humoral mediators on hypercytokinemic patients such as those with systemic inflammatory response syndrome. Furthermore, several clinical studies have demonstrated that selective digestive decontamination (SDD) effectively eliminates aerobic Gram-negative bacteria from the intestinal tract and reduces the incidence of septic complications in SAP. Herein we report a case of SAP who was treated successfully with intensive care including CHDF and SDD. Thus, this case report suggests that CHDF aimed at removing causative humoral mediators and SDD for the prevention of BT are useful new tools for the management of SAP.

[1]  M. West,et al.  Abdominal compartment syndrome in the intensive care unit. , 2001, Current opinion in critical care.

[2]  H. Hirasawa,et al.  Current topics on cytokine removal technologies. , 2001, Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis.

[3]  F. Motoi,et al.  Cytokine modulation in acute pancreatitis. , 2001, Journal of hepato-biliary-pancreatic surgery.

[4]  B. Rau,et al.  Prevention of severe change in acute pancreatitis: prediction and prevention. , 2001, Journal of hepato-biliary-pancreatic surgery.

[5]  M. Chang,et al.  Estimation of intra-abdominal pressure by bladder pressure measurement: validity and methodology. , 2001, The Journal of trauma.

[6]  K. Chu,et al.  Intra-abdominal hypertension and abdominal compartment syndrome , 2001, Langenbeck's Archives of Surgery.

[7]  H. Hirasawa,et al.  Endotoxin adsorption or hemodiafiltration in the treatment of multiple organ failure , 2000 .

[8]  H. Buhr,et al.  Does glutamine reduce bacterial translocation? A study in two animal models with impaired gut barrier , 1999, International Journal of Colorectal Disease.

[9]  P. Galanaud,et al.  Pro- and anti-inflammatory cytokines during acute severe pancreatitis: an early and sustained response, although unpredictable of death. Parisian Study Group on Acute Pancreatitis. , 1999, Critical care medicine.

[10]  H. Hirasawa,et al.  Blood Purification for Prevention and Treatment of Multiple Organ Failure , 1996, World Journal of Surgery.

[11]  R. Andersson,et al.  Gut Origin Sepsis, Macrophage Function, and Oxygen Extraction Associated with Acute Pancreatitis in the Rat , 1996, World Journal of Surgery.

[12]  J. Lange,et al.  Controlled Clinical Trial of Selective Decontamination for the Treatment of Severe Acute Pancreatitis , 1995, Annals of surgery.

[13]  P. Fabri,et al.  Decreased Mortality of Severe Acute Pancreatitis After Proximal Cytokine Blockade , 1995, Annals of surgery.

[14]  A. Nakao,et al.  Anti-neutrophil antibody attenuates the severity of acute lung injury in rats with experimental acute pancreatitis. , 1995, Archives of surgery.

[15]  T. Akizawa,et al.  Nafamostat as Anticoagulant for Membrane Plasmapheresis in high Bleeding risk Patients , 1992, The International journal of artificial organs.

[16]  H. Hirasawa,et al.  Nafamostat mesylate as anticoagulant in continuous hemofiltration and continuous hemodiafiltration. , 1991, Contributions to nephrology.